NCT00905931View on ClinicalTrials.gov

Lycopene Following Aneurysmal Subarachnoid Haemorrhage

PHASE2UnknownINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
Subarachnoid HemorrhageAneurysm
Interventions
DRUG

Lycopene

30 mg oral, daily, for 21 days

DRUG

placebo

starch

Trial Locations (1)

CB2 0QQ

Addenbrooke's Hospital, Cambridge

Sponsors
All Listed Sponsors
collaborator

Cambridge Theranostics Ltd

INDUSTRY

lead

University of Cambridge

OTHER

NCT00905931 - Lycopene Following Aneurysmal Subarachnoid Haemorrhage | Biotech Hunter | Biotech Hunter